Duquesne Family Office »

Xenon Pharmaceuticals shares owned by Duquesne Family Office

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by Duquesne Family Office from 13F filings

Historical chart of Duquesne Family Office investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by Duquesne Family Office

Quarter filed Position value Share count Share price at filing
2026-03-31 $14M 239k 58.15

More positions owned by Duquesne Family Office

Natera (NTRA)
Ishares Msci Brazil Etf (EWZ)
Insmed Com Par $.01 (INSM)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt Call Option (RSP)
Ypf Sociedad Anonima Spon Adr Cl D (YPF)
Bbb Foods Cl A Com (TBBB)
Alcoa (AA)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Sea Sponsord Ads (SE)
Stmicroelectronics N V Ny Registry (STM)
Woodward Governor Company (WWD)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Roku Com Cl A (ROKU)
Broadcom (AVGO)

View all positions for Duquesne Family Office

Top funds holding Xenon Pharmaceuticals

FMR
BlackRock
venBio Select Advisor
Wellington Management Company
Driehaus Capital Management
Henderson Group
Citadel Advisors
Capital Research and Management Company - Division 3
Polar Capital Holdings
Deerfield Management Company
Holocene Advisors
State Street Corporation
Alliancebernstein
Westfield Capital Management Company
Braidwell

View all funds holding Xenon Pharmaceuticals